After this, we analyzed elderly GBM patients under the WHO4 classification system in order to compare the differences in molecular features of elderly GBM patients under different classifications and found that KMT5B (p = 0.036) and NF1 (p = 0.011) alteration were associated with poorer prognosis (Figure 3A). This evidence concerns the gene KMT5B and glioblastoma.